News - UF Innovate

DNAtrix Announces Preclinical Data Demonstrating Anti-Tumor Activity of DNX-2401 in Models of Pediatric Tumors Published in Clinical Cancer Research

UF startup DNAtrix, a biotech company advancing virus-driven immunotherapies for cancer, announced preclinical data evaluating the use of DNX-2401 against the pediatric brain malignancies atypical teratoid/rhabdoid tumor (AT/RT) and primitive neuroectodermal tumors (PNETs) was published in Clinical Cancer Research.

Economic Impact

Despite the pandemic, University of Florida researchers conducted record amounts of research in 2020 and companies born of UF research continued to bring billions of dollars and thousands of jobs into the state.

UF Researcher Will Lead CureSearch for Children’s Cancer $1 Million Gift To Support Cutting-Edge Immunotherapy Trial for Pediatric High-Grade Glioma

CureSearch for Children’s Cancer has received a $1 million gift from the Norcross Family Foundation in support of a first-in-human, phase I/II clinical trial testing innovative personalized immunotherapy for pediatric high-grade gliomas, the primary cause of death in children with brain tumors. The project is funded through a CureSearch Catapult Award granted to pediatric oncologist Elias Sayour, MD, Ph.D. at the University of Florida.

Rekha Menon-Varma, Managing Partner at Vertaeon LLC, Receives the SPLC Award for Individual Leadership

The Sustainable Purchasing Leadership Council (SPLC) recognized Rekha Menon-Varma, managing partner of UF Innovate | The Hub resident company Vertaeon LLC, with the 2020 award for Individual Leadership, at the Council’s annual awards ceremony.

ASABE names AGROVIEW winner of a 2021 AE50 award

The American Society of Agricultural and Biological Engineers (ASABE) has named AGROVIEW winner of a 2021 AE50 award.

Field-Testing Natural Compounds To Fight HLB

Field tests of numerous antibacterial products and plant-derived compounds are underway with the goal of eliminating the HLB-causing bacteria in citrus and reversing plant damage to restore tree health.

Algernon Pharmaceuticals Signs Agreement with Charles River Laboratories for DMT Preclinical Studies

UF startup Algernon Pharmaceuticals Inc., formerly known as Breathtec Biomedical, announced that it has signed an agreement with Charles River Laboratories for preclinical studies of AP-188 (N,N-Dimethyltryptamine or DMT) for the company’s stroke clinical research program.

Free Tech Support for Low-Income Seniors Navigating Vaccine Registration

Orchard introduced a free assistance to low-income older adults to help them with the vaccine signup process.

Florida Breeding Seeks Regionally-Adapted Peach Rootstocks

University of Florida researchers are getting to the root of a problem faced by peach growers in the state. Their problem: The tree roots themselves, or the lack thereof.

UF Researchers Receive $1.46 Million Grant To Implement Alternatives to Opioids Program

Imagine a world where emergency room patients and providers have access to a menu of pain management treatment options that include a blend of traditional and integrative techniques. This is the vision held by a team at the University of Florida College of Medicine – Jacksonville looking to create a new way of caring for patients with a variety of pain conditions.

UF News